welcome
Guardian

Guardian

Health

Health

NHS cancer patients denied life-saving drugs due to Brexit costs, report finds

Guardian
Summary
Nutrition label

68% Informative

British cancer patients are being denied life-saving drugs and trials of revolutionary treatments are being derailed by the red tape and extra costs brought on by the EU .

The cost of importing new cancer drugs for Britons has nearly quadrupled as a result of post-Brexit red tape.

The extra rules and costs have had a “significant negative impact” on UK cancer research, a report warns.

Without it, patients will experience further delays to trials in future, it says.

Government has been providing extensive support for researchers to help them secure funding from the 80bn Horizon Europe programme.

Last year , the Guardian revealed how hundreds of thousands of people in the UK were being forced to wait months to begin even basic cancer treatment.

VR Score

76

Informative language

81

Neutral language

5

Article tone

formal

Language

English

Language complexity

61

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links